治験レーダーAI | ||
|---|---|---|
治験 NCT05699642 (Mind2Move)（対象：急性冠症候群、身体不活動）は募集中です。詳細は治験レーダーのタイル表示と AI 発見ツールで確認するか、ここで質問してください。 | ||
フィルター基準に一致する試験が1件見つかりました
タイル表示
Online Tai Chi Plus Fitbit After ACS (Mind2Move)
治験(臨床試験)の詳細は主に英語で提供されています。しかし、治験レーダーAIが支援できます！「治験を説明」をクリックして、選択した言語で試験情報を表示し、議論してください。
治験番号 NCT05699642 (Mind2Move) は 急性冠症候群、身体不活動 に関する その他 の研究で、第II相・第二段階 介入研究 臨床試験 です。現在は 募集中 で、2024年8月27日 から開始しています。70 名の参加者 の募集が計画されています。この治験は Beth Israel Deaconess Medical Center によって主催され、2025年11月30日 に完了予定です。ClinicalTrials.gov からの最新更新日は 2024年9月19日 です。
概要
This projects studies the role of tai chi exercise and wearable fitness trackers to promote physical activity in acute coronary syndrome (ACS) survivors.
詳細説明
This is a two-site randomized controlled trial taking place at Beth Israel Deaconess Medical Center in Boston, MA and The Miriam Hospital in Providence, RI. Seventy (n=70) physically inactive ACS survivors will be randomized to either a 6-month group tai chi program (remotely-delivered classes on Zoom) integrated with a wearable self-monitoring/feedback device plus enhanced usual care (EUC), or to EUC alone. EUC will include usual care provided by participants' providers integrated with printed CHD risk factor education materials. Assessments will be conducted in-person at baseline, 6 months (end of treatment), and 9 months. Our primary outcomes will be focused on study feasibility and acceptability. Secondary outcomes include the following patient-centered outcomes: objectively measured (via accelerometry) moderate-vigorous physical activity, light physical activity, sedentary time, cognitive-behavioral constructs (exercise self-efficacy, intrinsic motivation, depression, stress, HRQL), and cardiometabolic measures (exercise capacity, body weight, lipid profile, blood pressure, fasting plasma glucose).
公式タイトル
Tai Chi Exercise and Wearable Feedback Technology to Promote Physical Activity in Acute Coronary Syndrome Survivors
疾患／病気
急性冠症候群身体不活動その他の研究識別子
- Mind2Move
- 2022P000891
NCT番号
開始日
2024-08-27
最終更新日
2024-09-19
終了予定日
2025-11-30
目標参加者数
70
試験の種類
介入研究
治験の相・段階
第II相・第二段階
状況
募集中
キーワード
tai chi
fitness tracker
fitness tracker
主目的
その他
割付方法
無作為化
介入モデル
並行割当
盲検化
単盲検
群（アーム）／介入
| 参加グループ/群 | 介入/治療法 |
|---|---|
実験的Tai chi + wearable 48 virtual tai chi classes on Zoom over 6 months plus assigned home practice of tai chi 3x a week plus daily use of a Fitbit fitness tracker will be required for this group. | Tai CHI + Wearable The tai chi intervention will be delivered remotely via Zoom Enterprise. Participants will access classes on a phone, tablet, laptop, or desktop computer. Participants will attend 3 classes/week (each lasting 60 min) during weeks 1-12, 2 classes/week during weeks 13-16, and then 1 class every other week during weeks 17-24. Classes include tai chi warm-up exercises, breathing exercises, review and practice of tai chi forms, and cool-down exercises. Participants will be asked to practice tai chi at home 3x per week during the 6 month intervention period using an instructional video provided to them. The Fitbit fitness tracker will be given to each participant along with instructions on how to use the tracker and the Fitbit app on their personal device. |
非介入Enhanced usual care Printed educational materials based on existing resources (e.g., AHA; Centers for Disease Control and Prevention) will be shared with subjects in this group. | 該当なし |
主要評価項目
副次評価項目
| 評価指標 | 指標の説明 | 時間枠 |
|---|---|---|
Recruitment rate | Recruitment rate will be evaluated with respect to rate of enrollment, defined as randomization into the trial. | Through study completion (an average of 3 years) |
Retention rate | Retention rate will be quantified by the proportion of subjects who remain in the study to complete our 9-month visit. | Through study completion (an average of 3 years) |
Intervention enjoyment | Intervention enjoyment will be assessed via qualitative interviews | 6 months |
Intervention adherence | Intervention adherence will be measured by collection of class attendance and home practice data. | Through study completion (an average of 3 years) |
| 評価指標 | 指標の説明 | 時間枠 |
|---|---|---|
Physical activity | Physical activity will be measured using accelerometers (Actigraph model wGT3X-BT, LLC, Fort Walton Beach, FL). | Baseline, 6 and 9 months |
Systolic and diastolic blood pressure | Blood pressure will be measured using a Dinamap XL automated BP monitor according to current recommendations. | Baseline, 6 and 9 months |
Body weight | Body weight will be measured using an electronic scale. | Baseline, 6 and 9 months |
Height | Height will be measured using a tape measure. | Baseline |
Fasting glucose | Fasting glucose will be measured after a 12-hour fast according to standardized procedures. All blood samples will be sent to and analyzed at the Lifespan Laboratory located at the Rhode Island Hospital/The Miriam Hospital. | Baseline, 6 and 9 months |
Lipid panel | Lipid panel will be measured after a 12-hour fast according to standardized procedures. All blood samples will be sent to and analyzed at the Lifespan Laboratory located at the Rhode Island Hospital/The Miriam Hospital. | Baseline, 6 and 9 months |
hs-CRP | hs-CRP will be measured after a 12-hour fast according to standardized procedures. All blood samples will be sent to and analyzed at the Lifespan Laboratory located at the Rhode Island Hospital/The Miriam Hospital. | Baseline, 6 and 9 months |
Quality of life assessed by SF-36 | Quality of life will be measured using a short version (8 items) of the Health Survey Short Form (SF-36). Scores range from 0-100, with a higher score indicating a higher quality of life. | Baseline, 6 and 9 months |
Intrinsic motivation | Intrinsic Motivation Inventory is a 22-item scale validated with four sub-scales: interest/enjoyment, perceived competence, perceived choice, and pressure/tension. A higher score is better, with a scoring range of 22-154. | Baseline, 6 and 9 months |
Anxiety, Depression | Anxiety, Depression will be assessed using the Hospital Anxiety and Depression Scale, a self-administered questionnaire with two sub-scales (0-21) measuring anxiety and depression, with higher scores indicating greater psychological morbidity. | Baseline, 6 and 9 months |
Stress | Stress will be measured using the Perceived Stress Scale (PSS) - a 10 items survey with scores ranging from 0 to 40, and higher scores indicating greater stress burden. | Baseline, 6 and 9 months |
Mindful awareness | Mindful awareness will be assessed using the Five Facets of Mindfulness questionnaire (short form) a 15-item questionnaire that measures the five identified components of mindfulness meditation: observing, acting with awareness, non-judging of inner experience, and non-reactivity to inner experience. Scores ranges from 39-19, with a higher score being better. | Baseline, 6 and 9 months |
Exercise self-efficacy | Exercise self-efficacy will be measured using the Self-Efficacy for Exercise Scale. This is a 9-item validated scale from McAuley's original barriers scale. Scores range form 9-28, with a higher score meaning more self-efficacy. | Baseline, 6 and 9 months |
Exercise capacity | Exercise capacity will be assessed via the 6 min walk test (6MWT), a simple, safe and reliable first-line assessment of functional status that correlates with peak oxygen uptake. | Baseline, 6 and 9 months |
適格基準
対象年齢
成人, 高齢者
試験の最低年齢
18 Years
対象性別
全て
- History of ACS (unstable angina, NSTEMI, and STEMI, defined per current AHA/ACC criteria);
- Age ≥ 18;
- Being physically inactive (i.e., < 150 min/week of moderate-intensity aerobic PA);
- Absence of contraindications to physical exercise per the participant's provider evaluation;
- Access to a digital device with internet connection;
- Having an active email account and ability to check email at least weekly;
- Physician clearance to participate in low-moderate intensity exercise (tai chi), including a statement that there is no contraindication to exercise based on post-ACS stress test and other factors, as appropriate;
- English speaking
- Inability or unwillingness to give informed consent;
- Blood pressure >200/110 or orthostatic systolic blood pressure decrease >20 mmHg at the baseline visit;
- Uncontrolled/untreated atrial or ventricular arrhythmias or 3rd degree AV block;
- Within 3 months of a diagnosis of pericarditis or myocarditis;
- Medical conditions likely to limit lifespan to less than one year;
- New York Heart Association (NYHA) functional class IV;
- Severe cognitive impairment (BOMC >10);139
- Orthopedic problems prohibiting TC practice;
- Ongoing TC or other mind-body training (i.e., meditation, TC, or yoga) at least weekly;
- Current enrollment in cardiac rehabilitation;
- Untreated severe depression (PHQ>=20);
- Conditions likely to affect study compliance (i.e., moving out of study area, substance use, ongoing untreated psychosis);
- Symptoms of unstable cardiovascular disease (e.g., shortness of breath or chest pain at rest and/or Canadian Cardiovascular Society Angina Class III-IV)
Beth Israel Deaconess Medical CenterLifespan責任者
Gloria Y. Yeh, 研究責任者, Principal Investigator, Beth Israel Deaconess Medical Center
試験中央連絡先
連絡先: Daniel Litrownik, BA, 617-754-1423, [email protected]
1 1カ国の場所
Massachusetts
Beth Israel Deaconess Medical Center, Boston, Massachusetts, 02215, United States
Research Assistant, 連絡先, 617-754-1428, [email protected]
募集中